This Week in PLoS Medicine: Flu treatment combo; eHealth evaluation; Pharmaceutical promotion perspective

Three new articles were published this week in PLoS Medicine, including a perspective on an article from our October issue.

Analysis of virological and clinical outcomes from a randomized trial that was terminated early suggests that combined treatment of seasonal influenza in adult outpatients with oseltamivir plus zanamivir is no more effective than either oseltamivir or zanamivir monotherapy.

Trisha Greenhalgh and Jill Russell discuss the relative merits of “scientific” and “social practice” approaches to evaluation and argue that eHealth evaluation is in need of a paradigm shift.

David Henry discusses a research article by Geoffrey Spurling and colleagues that examined the relationship between exposure to promotional material from pharmaceutical companies and the quality, quantity, and cost of prescribing.

Remember you can comment on, annotate and rate any PLoS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.